In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nestle Good Start soy

This article was originally published in The Tan Sheet

Executive Summary

Nestle launches Good Start Supreme Soy DHA & ARA infant formula, firm announces Nov. 11. The lactose-free formula contains the fatty acids docosahexaenoic acid and arachidonic acid for healthy brain and eye development. A milk-based Supreme formula launched last year (1"The Tan Sheet" Sept. 29, 2003, p. 13). The products will retail in a 32 oz. ready-to-feed container for $5.72, a 13 oz. concentrate for $4.11 and 12.9 oz. and 25.7 oz. powder containers for $12.54 and $22.92, respectively...

You may also be interested in...

Nestle Restages Good Start Brand, Adds ARA, DHA-Enriched Formula

Ads focusing on Nestle Good Start Supreme DHA & ARA infant formula are breaking as the new product reaches full distribution, Nestle said

Keeping Track: US FDA Clears Esperion’s Nexletol, Baudax’ Anjeso, Agile’s Twirla

The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.

Esperion’s Nexletol Reaches The Cholesterol Market Priced To Sell

Esperion obtained an on-time approval of Nexletol (bempedoic acid) for a pair of LDL cholesterol-lowering indications on 21 February. 





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts